Nội dung chính của bài viết
The study aimed to evaluate the acute and subchronic toxicities of “Phuong Dong Dai Trang” tablets through oral administration using experimental animal models. Acute toxicity in Swiss mice was determined using the Litchfield Wilcoxon method. The subchronic toxicity in Wistar rats was evaluated according to WHO and OECD’s recommendation with oral doses of 4.68 g/kg/day (equivalent to recommended human dose) and 14.04 g/kg/day (3 times the recommended human dose) for 4 consecutive weeks. In terms of acute toxicity, “Phuong Dong Dai Trang” tablets did not express acute toxicity in mice at the highest dose used (232.14 g materials/kg). In terms of the subchronic toxicity, after oral administration of “Phuong Dong Dai Trang” tablets, hematological parameters, hepato - renal functions, and microscopic images of liver and kidney were unchanged in the treatment group compared to the control group. In conclusion, “Phuong Dong Dai Trang” tablets did not produce acute and subchronic toxicities in Swiss mice and Wistar rats.
Chi tiết bài viết
“Phuong Dong Dai Trang”, acute toxicity, subchronic toxicity, experimental animals.
Tài liệu tham khảo
2. World Health Organization, Global report on traditional and complementary medicine; 2019.
3. Venkatasubbu GD, Ramasamy S, Gaddam PR, et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine. 2015;10:137 - 148.
4. De Jong WH, Carraway JW, Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices. 2012;120 - 158.
5. SAGANUWAN SA. Toxicity studies of drugs and chemicals in animals: an overview. Bulgarian Journal of Veterinary Medicine. 2017;4(20):291 - 318.
6. OECD, Guidelines for the testing of chemicals repeated dose oral toxicity study in rodents,. Environmental Health and Safety Monograph Series on Testing and Assesment No 407; 2008.
7. World Health Organization, Guidelines for Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues. World Health Organization, Geneva; 2007.
8. Litchfield J T& Wilcoxon F A. A simplified method of evaluating dose - effect experiments. J. Pharmacol. Exp. Ther. 1949;96:99 - 113.
9. World Health Organization, Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization; 2000.
10. Lee M, Seo C, Cha S, et al. Safety assessment of So - cheong - ryong - tang: subchronic toxicity study in Crl: CD Sprague Dawley rats. Mol Med Rep. 2014;9:2273–2282.
11. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology. 2000;32(1):56–67.
12. Hirotaka H, Takanari A, Jeffry MS, Harukuni T, Yasuko S, Yasuyuki O, Toshiki E, Kazuo U, Tomihisa O, Nobutaka S. 28 - day Repeated Dose Oral Toxicity Test of Coix lacryma - jobi L. var. ma - yuen Stapf in Rats. JJCAM. 2009 Oct. ;6 (3):131–135.